Skip to content

Effect of an oral nutrition supplementation containing carboxymethylpachymaran (CMP) on the nutritional status and quality of life of nasopharyngeal carcinoma patients with radiation and chemotherapy

Effect of an oral nutrition supplementation containing carboxymethylpachymaran (CMP) on the nutritional status and quality of life of nasopharyngeal carcinoma patients with radiation and chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ION-15006545
Enrollment
Unknown
Registered
2015-06-12
Start date
2015-06-05
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma with radiation and chemotherapy

Interventions

Group A:take enteral nutrition supplementation containing carboxymethylpachymaran (CMP)

Sponsors

Cancer Hospital Affiliated to Shanghai Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Nasopharyngeal carcinoma patients: Stage III, IV(AJCC/UICC 2010) with radiation and chemotherapy; 2. With clear pathology.

Exclusion criteria

Exclusion criteria: 1. With distant metastasis; 2. Age: 18-70 y; 3. Patients with severe primary disease,such as heart, brain, liver, kidney disease or patients with metabolic disease,such as diabetes or patients with psychosis; 4. Patients with a second primary tumor; 5. During pregnancy and puerperium; 6. Patients taking other supplements; 7. Patients didn't sign informed consent.

Design outcomes

Primary

MeasureTime frame
weight;Albumi;prealbumin;transferrin;CD3+;CD4+;CD8+;CD8+;

Secondary

MeasureTime frame
height;PGSGA;Diet reviews;quality of life;Body composition;

Countries

China

Contacts

Public ContactShen Chunying
shency2005@yahoo.com+86 13564000658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026